Same here.
I like what they are doing ... and hope they can commercialise what I think is a great breakthrough for ovarian cancer detection (at an early stage when it is potentially treatable with success) and turn it into a great investment.
As its a test/procedure done outside the body, obtaining FDA approval should be not as ‘difficult’ as say for a new treatment drug. More a matter of proving its clinical accuracy in detection ...ie low percentages of ‘false negatives’ and ‘false positives’.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.020(5.00%) |
Mkt cap ! $31.00M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 38.0¢ | $20.50K | 51.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7894 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 11.51am 31/07/2025 (20 minute delay) ? |
| COV (ASX) Chart |